Nervous System Active Pharmaceutical Ingredients Market Players:
- Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Company
- Shenzhen Hepalink Pharmaceutical Co. Ltd.
- GSK plc
- F. Hoffmann-La Roche Ltd
- Cipla Inc.
- Eli Lilly and Company
- Novartis AG,
- Teva Pharmaceutical Industries Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of nervous system active pharmaceutical ingredients is evaluated at USD 246.85 billion.
The global nervous system active pharmaceutical ingredients market size was worth more than USD 236.63 billion in 2025 and is poised to witness a CAGR of over 4.8%, crossing USD 378.17 billion revenue by 2035.
Asia Pacific is projected to hold a 30% revenue share of the Nervous System Active Pharmaceutical Ingredients Market by 2035, driven by rising healthcare spending.
Key players in the market include Pfizer, Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Shenzhen Hepalink Pharmaceutical Co. Ltd., GSK plc, F. Hoffmann-La Roche Ltd, Cipla Inc., Eli Lilly and Company, Novartis AG, Teva Pharmaceutical Industries Ltd.
